"17312-021-14" National Drug Code (NDC)

Sciatica Therapy 1 BOTTLE in 1 PACKAGE (17312-021-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE
(TRP Company)

NDC Code17312-021-14
Package Description1 BOTTLE in 1 PACKAGE (17312-021-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE
Product NDC17312-021
Product Type NameHUMAN OTC DRUG
Proprietary NameSciatica Therapy
Non-Proprietary NameArnica Montana - Citrullus Colocynthis Fruit Pulp - Pseudognaphalium Obtusifolium - Hypericum Perforatum - Potassium Iodide - Magnesium Phosphate, Dibasic Trihydrate - Toxicodendron Pubescens Leaf -
Dosage FormTABLET, ORALLY DISINTEGRATING
UsageORAL
Start Marketing Date20111201
Marketing Category NameUNAPPROVED HOMEOPATHIC
ManufacturerTRP Company
Substance NameARNICA MONTANA; CITRULLUS COLOCYNTHIS FRUIT PULP; HYPERICUM PERFORATUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM IODIDE; PSEUDOGNAPHALIUM OBTUSIFOLIUM; TOXICODENDRON PUBESCENS LEAF
Strength6; 6; 6; 6; 6; 6; 6
Strength Unit[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1
Pharmacy ClassesCalculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/17312-021-14